TCL Archive Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard February 22, 2013
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
